| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.75B | -3.3% |
| R&D Expense | $625.0M | -8.9% |
| SG&A Expense | $3.09B | -3.3% |
| Operating Income | $2.17B | -17.9% |
| Interest Expense | $458.0M | -21.0% |
| Pre-tax Income | $1.80B | -20.9% |
| Income Tax | $240.0M | -77.4% |
| Net Income | $1.48B | -73.5% |
| EPS (Basic) | $1.74 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.55B | -60.8% |
| Accounts Receivable | $2.64B | -0.5% |
| Inventory | $2.48B | +8.0% |
| Current Assets | $8.53B | -13.7% |
| Total Assets | $37.19B | -0.6% |
| Current Liabilities | $7.11B | -9.9% |
| Long-term Debt | $11.37B | +3.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.51B | +346.4% |
| Investing Cash Flow | -$307.0M | +84.8% |
| Financing Cash Flow | -$4.67B | -0.8% |
| -72.1% |
| EPS (Diluted) | $1.72 | -72.0% |
| Total Liabilities |
| $23.06B |
| +0.2% |
| Stockholders' Equity | $14.13B | -1.9% |